Platelet‐Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 3432987-7
Abstract
Introduction. Literature shows platelet‐rich plasma (PRP) to improve overall outcomes in orthopedics, dermatology, ophthalmology, gynecology, and plastic surgery. Data on oncological patients is very limited. Only one publication is available on PRP in breast cancer patients. This work evaluated PRP in sentinel node biopsy procedures for breast cancer patients in terms of complication rates and oncological short‐term follow‐up. Methods. The evaluated PRP was ACP®, i.e., autologous conditioned plasma by Arthrex®. Between 2015 and 2018, 163 patients were offered to receive an ACP®/PRP injection in their lymph node biopsy site. Recruitment resulted in an approximate one‐to‐one ratio for analysis. Endpoints were major (revision) and minor (seroma, hematoma, and infection) complications rates as well as distant metastases, local recurrence, and overall survival. Median follow‐up was 30 months. Results. Complication rates and oncological follow‐up showed PRP to be applicable to use in a sentinel node biopsy scenario in breast cancer patients. There were 0 revisions in the ACP®/PRP group and 1.2% revisions in the control group (not significant). Oncological follow‐up showed zero (0) distant metastases and local recurrences as well as a 100% 30‐month overall survival. Conclusions. This is the first analysis of ACP®/PRP used in breast cancer patients in a sentinel node biopsy setting worldwide. PRP does not seem to increase rates of local recurrence within this 30‐month follow‐up time frame. Also, trend towards decreasing complication rates could be shown.Keywords
This publication has 21 references indexed in Scilit:
- A Head-to-head Comparison between SurgiMend and Epiflex in 127 Breast ReconstructionsPlastic and Reconstructive Surgery - Global Open, 2015
- Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblastsExperimental Eye Research, 2015
- Platelet-Rich Plasma in the Treatment of Subcutaneous Venous Access Device Scars: A Head-to-Head Patient SurveyBioMed Research International, 2015
- Platelet‐Rich Plasma in Arthroscopic Rotator Cuff Repair: A Meta‐analysis of Randomized Controlled TrialsArthroscopy, 2014
- Platelet Rich Plasma and Knee SurgeryBioMed Research International, 2014
- Does intra articular platelet rich plasma injection improve function, pain and quality of life in patients with osteoarthritis of the knee? A randomized clinical trialOrthopedic Reviews, 2014
- [Platelet-rich plasma for treating acute wounds: a meta-analysis].2014
- Overview of Surgical Scar Prevention and ManagementJournal of Korean Medical Science, 2014
- IDEAL framework for surgical innovation 1: the idea and development stagesBMJ, 2013
- Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral headStem Cell Research & Therapy, 2012